immunology of infectious and parasitic diseases - XXXVII Congress ...
immunology of infectious and parasitic diseases - XXXVII Congress ...
immunology of infectious and parasitic diseases - XXXVII Congress ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
STUDYING THE INFLAMMATORY RESPONSES TRIGGERED BY<br />
STREPTOCOCCUS PNEUMONIAE INFECTION IN A MURINE MODEL –<br />
EFFECTS OF A PDE4 INHIBITOR<br />
LUCIANA PÁDUA TAVARES 1,2 , CRISTIANA COUTO GARCIA 1 , JULIANA<br />
PRISCILA VAGO DA SILVA 2 , RAQUEL GREGORIO ARRIBADA 2 , MAURO<br />
MARTINS TEIXEIRA 1 , LIRLÂNDIA PIRES SOUSA²<br />
¹Laboratório de Imun<strong>of</strong>armacologia, Departamento de Bioquímica e Imunologia,<br />
ICB, UFMG<br />
²Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia,<br />
UFMG<br />
Introduction <strong>and</strong> Objectives: Pneumonia, caused most frequently by<br />
Streptococcus pneumoniae, is a major global health problem <strong>and</strong> is a leading<br />
cause <strong>of</strong> morbidity <strong>and</strong> mortality worldwide, especially in developing countries.<br />
The inflammatory response that follows microbial infections controls<br />
dissemination <strong>of</strong> bacteria but may also cause tissue damage <strong>and</strong> mortality.<br />
Drugs such as phosphodiesterase 4 (PDE4) inhibitors decrease inflammatory<br />
responses effectively. Here, we describe the establishment <strong>of</strong> an animal model<br />
<strong>of</strong> S. pneumoniae infection <strong>and</strong> evaluated whether the anti-inflammatory action<br />
<strong>of</strong> PDE4 inhibitors interferes with the ability <strong>of</strong> the murine host to deal with<br />
infection.Methods <strong>and</strong> Results: Male Balb/C mice were infected intranasally<br />
with S. pneumoniae serotype 3 (ATCC 6303, 10 3 -10 6 CFU). Weight loss <strong>and</strong><br />
lethality were accompanied from the first day <strong>of</strong> infection (n=6 per group). There<br />
was an inoculum-dependent death rate(10 6 <strong>and</strong> 10 5 CFU caused 100%, while<br />
10 4 CFU caused 67% <strong>and</strong> 10 3 CFU 50% <strong>of</strong> lethality). Mice were infected with<br />
10 5 CFU (100% lethality rate at day 4) <strong>and</strong> killed at 1, 2 or 3 days after infection.<br />
Lung neutrophils (assessed by myeloperoxidase levels) <strong>and</strong> airway neutrophils<br />
(recovered by bronchoalveolar lavage - BAL) peaked at 1 day after infection<br />
<strong>and</strong> declined thereafter. Inflammatory mediators (TNF-α <strong>and</strong> CXCL1/KC),<br />
phagocytosis <strong>and</strong> number <strong>of</strong> bacteria in BAL fluid had similar kinetics.<br />
Treatment with Rolipram (ROL, 6 mg/kg, 1 h before infection) decreased<br />
neutrophil recruitment in lungs, but not in BAL fluid, <strong>and</strong> decreased levels <strong>of</strong><br />
cytokines in BAL fluid at 24 h. Number <strong>of</strong> bacteria in BAL fluid were similar in<br />
Rolipram <strong>and</strong> vehicle-treated animals. The percentage <strong>of</strong> leukocytes<br />
phagocytosing bacteria was slightly greater in drug-treated animals.